Search Results - "Bahceci, Aykut"

The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer by Bahçeci, Aykut, Kötek Sedef, Ayşe, Işik, Deniz

“…We aimed to assess the prognostic and predictive significance of pretreatment Prognostic Nutritional Index (PNI) in extensive-stage small-cell lung cancer…”
Get full text

Use of pertuzumab and trastuzumab during pregnancy by Yildirim, Nilgun, Bahceci, Aykut

“…Trastuzumab and pertuzumab are monoclonal antibodies used for the treatment of breast cancer. Until now, there have been no reports on the use of pertuzumab…”
Get full text

Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells by Kacan, Turgut, Altun, Ahmet, Altun, Gulsah Gultekin, Kacan, Selen Baloglu, Sarac, Bulent, Seker, Mehmet Metin, Bahceci, Aykut, Babacan, Nalan

“…Background: Breast cancer evolution and tumor progression are controlled by complex interactions between steroid receptors and growth factor receptor…”
Get full text

Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers? by Kacan, Turgut, Babacan, Nalan Akgul, Seker, Metin, Yucel, Birsen, Bahceci, Aykut, Eren, Ayfer Ay, Eren, Memet Fuat, Kilickap, Saadettin

“…Background: Although many prognostic factors have been identified for lung cancers, new ones are needed to determine the course of the disease. Recently, a…”
Get full text

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study by Hizal, Mutlu, Bilgin, Burak, Paksoy, Nail, Açıkgöz, Özgür, Sezer, Ahmet, Gürbüz, Mustafa, Ak, Naziye, Yücel, Şebnem, Ayhan, Murat, Erol, Cihan, Demirkıran, Aykut, Mandel, Nil Molinas, Shbair, Abdallah, Gökmen, İvo, Başoğlu, Tuğba, Paydaş, Semra, Demiray, Atike Gökçen, İriağaç, Yakup, Şakalar, Teoman, Zeynelgil, Esra, Tatlı, Ali Murat, Bahçeci, Aykut, Güven, Deniz Can, Caner, Burcu, Can, Alper, Gülmez, Ahmet, Karakaş, Yusuf, Yalçın, Bülent, Demirkazık, Ahmet, Bilici, Ahmet, Aydıner, Adnan, Yumuk, Perran Fulden, Şendur, Mehmet Ali Nahit

“…Introduction Osimertinib, an irreversible third-generation EGFR-TKI, is the standard of care for second-line treatment of T790M-mutant advanced NSCLC patients…”
Get full text

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial by Yılmaz, Feride, Yaşar, Serkan, Mandel, Nil Molinas, Kaçan, Turgut, Özdemir, Melek, Doğu, Gamze Gököz, Şengül, Nilay, Meydan, Nezih, Başal, Fatma Buğdaycı, Tolunay, Pınar Kubilay, Hamamcı, Melda Berber, Dinçer, Oğuz Salih, Bahçeci, Aykut, Özer, Leyla, Ajredini, Miraç, Kırca, Önder, Yersal, Özlem, Can, Orçun, Günaldı, Meral, Demir, Gökhan, Yalçın, Şuayib

“…Background Neurotrophic tyrosine receptor kinase (NTRK) gene fusions represent rare somatic mutations in many types of cancer and have enabled the use of…”
Get full text

XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology by Duran, Ayse Ocak, Karaca, Halit, Besiroglu, Mehmet, Bayoglu, Ibrahim Vedat, Menekse, Serkan, Yapici, Heves Surmeli, Yazilitas, Dogan, Bahceci, Aykut, Uysal, Mukremin, Sevinc, Alper, Hacibekiroglu, Ilhan, Aksoy, Asude, Tanriverdi, Ozgur, Arpaci, Erkan, Inanc, Mevlude, Dane, Faysal, Ozkan, Metin

“…Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic…”
Get full text

Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience by Bahçeci, Aykut, Paydaş, Semra, Ak, Naziye, Ferhatoğlu, Ferhat, Saip, Pınar Mualla, Seydaoğlu, Gülşah, Bilici, Mehmet, Şimşek, Melih, Tekin, Salim Başol, Çalikuşu, Züleyha, Yavuz, Sinan, Şahin, Ahmet Bilgehan, Çubukçu, Erdem, Evrensel, Türkkan, Değirmencioğlu, Serkan, Demiray, Atike Gökçen, Yumuk, Perran Fulden, Alan, Özkan, Çikman, Duygu İlke, Demirelli, Fuat Hulusi, Köstek, Osman, Gökyer, Ali, Doğan, Mutlu, Bal, Öznur, Çakar, Burcu, Gökmen, Erhan, Yamaç, Deniz, Korkmaz, Taner, Aliyev, Altay, Keskin, Özge, Urvay, Semiha, Büyükşimşek, Mahmut, Karadeniz, Cemile, Yildiz, Birol, Çinkir, Havva Yeşil, Demir, Hacer, Beypinar, İsmail, Karaçin, Cengiz, Eser, Kadir, Baykara, Meltem, Kiliçkap, Saadettin, Okutur, Kerem, Bulut, Gülcan, Alkan, Ali, Arpaci, Erkan, Pilanci, Kezban Nur, Demir, Atakan, Işik, Deniz, Yildirim, Nilgün

“…The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines…”
Get full text

The Prognostic Significance of Complete Response Rates in Patients with Extensive Stage Small Cell Lung Cancer by Sedef, Ali Murat

“…OBJECTIVE Small cell lung cancer (SCLC) is the most aggressive type of lung cancer. Platinum-etoposide chemotherapy combination is used as first line…”
Get full text

Pleural involvement in plasma cell neoplasm by Paydaş,Semra, Uğuz,Aysun, Kılıç Bağır,Emine, Bahçeci,Aykut

“…Myelomatous pleural effusion (MPE) is very rare and has a very poor prognosis. The effusion is thought to be a late manifestation of the disease and MPE is a…”
Get full text

The negative prognostic impact of bone metastasis with a tumor mass by Yücel, Birsen, Celasun, Mustafa Gürol, Öztoprak, Bilge, Hasbek, Zekiye, Bahar, Seher, Kaçan, Turgut, Bahçeci, Aykut, Şeker, Mehmet Metin

“…Typically, bone metastasis causes osteolytic and osteoblastic lesions resulting from the interactions of tumor cells with osteoclasts and osteoblasts. In…”
Get full text

Prognostic value of basal neutrophil lymphocyte ratio in patients with extensive stage small cell lung cancer by Bahçeci,Aykut, Sedef,Ali Murat, Sümbül,Ahmet Taner, Besen,Ali Ayberk, Çalıkuşu,Züleyha, Gökçay,Serkan

“…Purpose: The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocytopenia are markers of poor prognosis in lung cancer patients. The…”
Get full text

The prognostic value of UHRF-1 and p53 in gastric cancer by Babacan, Nalan A, Egilmez, Hatice Reyhan, Yücel, Birsen, Ilknur, Parlak, Seker, Mehmet Metin, Kacan, Turgut, Bahceci, Aykut, Cihan, Sener, Akinci, Bülent, Eriten, Berna, Kilickap, Saadettin

“…This study aimed to examine whether UHRF-1 and p53 overexpression is a prognostic marker for gastric cancer. Sixty-four patients with gastric cancer (study…”
Get full text

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Aydin, Sabin Goktas, Eraslan, Emrah, Kaplan, Muhammed Ali, Ocak, Birol, Goksu, Sema Sezgin, Paydas, Semra, Akgul, Fahri, Derin, Sumeyye, Ergun, Yakup, Yekeduz, Emre, Erol, Cihan, Ozyukseler, Deniz Tataroglu, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Cinkir, Havva Yesil, Gumusay, Ozge, Sakin, Abdullah, Ozkul, Ozlem, Demir, Hacer, Erdem, Dilek, Besiroglu, Mehmet, Unal, Olcun Umit, Acar, Ramazan, Koral, Lokman, Sahin, Suleyman, Sakalar, Teoman, Bahceci, Aykut, Ozveren, Ahmet, Gunaydin, Ulug Mutlu, Seker, Mehmet Metin, Sunar, Veli, Dal, Pinar, Artac, Mehmet, Turhal, Serdar

“…Aim Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS)…”
Get full text

Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) study by Kus, Tulay, Aktas, Gokmen, Ozcelik, Melike, Dirikoc, Merve, Sakalar, Teoman, Oyman, Abdilkerim, Tanriverdi, Ozgur, Yavuzsen, Tugba, Unal, Sinan, Cinkir, Havva Yesil, Bahceci, Aykut, Alkan, Ali, Turhal, Serdar, Abali, Huseyin

“…Chemotherapy-induced nausea and vomiting (CINV) may be linked to the psychological status of cancer patients. Therefore, the authors aimed to better understand…”
Get full text

Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? by Kacan, Turgut, Babacan, Nalan Akgul, Seker, Metin, Yucel, Birsen, Bahceci, Aykut, Eren, Ayfer Ay, Eren, Mehmet Fuat, Kilickap, Saadettin

“…Although many prognostic factors have been identified for lung cancers, new ones are needed to determine the course of the disease. Recently, a high neutrophil…”
Get full text

Prognostic value of serum TIE-2 and vascular endothelial growth factor levels in gastric cancer patients by Seker, Mehmet Metin, Sancakdar, Enver, Seker, Ayse, Bahceci, Aykut, Kacan, Turgut, Babacan, Nalan

“…Abstract only…”
Get full text

Could the neutrophil to lymphocyte ratio be a poor prognostic factor for lung cancers? by Kacan, Turgut, Babacan, Nalan, Seker, Mehmet Metin, Yucel, Birsen, Bahceci, Aykut, Gedikli, Mustafa Asim, Kilickap, Saadettin

“…Abstract only…”
Get full text

DNA repair gene polymorphisms in B cell non-Hodgkin’s lymphoma by Bahceci, Aykut, Paydas, Semra, Tanriverdi, Kahraman, Ergin, Melek, Seydaoglu, Gulsah, Ucar, Gulsum

“…Cancer is a group of diseases characterized by DNA injury, and genetic and environmental factors are important in the etiology of the cancers. It is well known…”
Get full text

Serum leptin and adiponectin levels and relationship with prognosis in lung cancer by Seker, Mehmet Metin, Sancakdar, Enver, Nadir, Aydin, Altun, Gulsah, Bahceci, Aykut, Kacan, Turgut, Babacan, Nalan, Kaptanoglu, Melih

“…Abstract only…”
Get full text